DK162102C - Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf

Info

Publication number
DK162102C
DK162102C DK126679A DK126679A DK162102C DK 162102 C DK162102 C DK 162102C DK 126679 A DK126679 A DK 126679A DK 126679 A DK126679 A DK 126679A DK 162102 C DK162102 C DK 162102C
Authority
DK
Denmark
Prior art keywords
sojasapogenol
glucoronopyranosyl
analogue
beta
preparation
Prior art date
Application number
DK126679A
Other languages
English (en)
Other versions
DK162102B (da
DK126679A (da
Inventor
Masanao Shinohara
Yoshimasa Nakano
Hirotsugu Kaise
Taketoshi Izawa
Wasei Miyazaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK126679A publication Critical patent/DK126679A/da
Publication of DK162102B publication Critical patent/DK162102B/da
Application granted granted Critical
Publication of DK162102C publication Critical patent/DK162102C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK126679A 1978-03-31 1979-03-28 Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf DK162102C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53038536A JPS5822120B2 (ja) 1978-03-31 1978-03-31 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ
JP3853678 1978-03-31

Publications (3)

Publication Number Publication Date
DK126679A DK126679A (da) 1979-10-01
DK162102B DK162102B (da) 1991-09-16
DK162102C true DK162102C (da) 1992-02-24

Family

ID=12527996

Family Applications (1)

Application Number Title Priority Date Filing Date
DK126679A DK162102C (da) 1978-03-31 1979-03-28 Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf

Country Status (23)

Country Link
US (1) US4217345A (da)
JP (1) JPS5822120B2 (da)
AR (1) AR227624A1 (da)
AT (1) AT369426B (da)
AU (1) AU527201B2 (da)
BE (2) BE875105A (da)
CA (1) CA1128498A (da)
CH (1) CH640868A5 (da)
DE (1) DE2911353A1 (da)
DK (1) DK162102C (da)
ES (2) ES478874A1 (da)
FI (1) FI67559C (da)
FR (1) FR2421179A1 (da)
GB (1) GB2020290B (da)
IT (1) IT1126812B (da)
MX (1) MX6305E (da)
NL (1) NL7902449A (da)
NO (1) NO154584C (da)
PH (1) PH16275A (da)
PT (1) PT69423A (da)
SE (1) SE434269B (da)
SU (2) SU1074408A3 (da)
ZA (1) ZA791061B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US6784159B2 (en) * 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
EP1422509A1 (en) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysing Reagent and Method of Lysing Red Blood Cells for Hematology
JP4960096B2 (ja) * 2003-09-22 2012-06-27 ペントラコール ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｉｌ−６の生物学的効果を減じる化合物の使用
US20070141121A1 (en) * 2005-12-20 2007-06-21 Calton Gary J Method of treating kidney disease
JP6018571B2 (ja) * 2011-06-28 2016-11-02 株式会社Ｊ−オイルミルズ ソーヤサポゲノール組成物
CN106589043B (zh) * 2015-10-16 2019-02-26 复旦大学 芳基取代丙烯酰基三萜类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377001A (en) * 1976-11-16 1978-07-08 Otsuka Pharmaceut Co Ltd New material and its preparation
JPS5399314A (en) * 1977-02-04 1978-08-30 Otsuka Pharmaceut Co Ltd Therapeutic agent for nephritis
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents

Also Published As

Publication number Publication date
GB2020290A (en) 1979-11-14
DE2911353A1 (de) 1979-10-11
FR2421179B1 (da) 1983-03-18
AT369426B (de) 1982-12-27
NL7902449A (nl) 1979-10-02
NO154584C (no) 1986-11-05
IT7948551A0 (it) 1979-03-30
SU1190989A3 (ru) 1985-11-07
PT69423A (en) 1979-04-01
IT1126812B (it) 1986-05-21
AR227624A1 (es) 1982-11-30
DK162102B (da) 1991-09-16
PH16275A (en) 1983-08-26
FI67559B (fi) 1984-12-31
ES478874A1 (es) 1980-10-01
BE875105A (fr) 1979-09-26
SU1074408A3 (ru) 1984-02-15
MX6305E (es) 1985-03-29
CA1128498A (en) 1982-07-27
NO154584B (no) 1986-07-28
US4217345A (en) 1980-08-12
ATA236079A (de) 1982-05-15
FI791011A (fi) 1979-10-01
AU527201B2 (en) 1983-02-24
FI67559C (fi) 1985-04-10
AU4499579A (en) 1979-10-04
ES8102148A1 (es) 1981-01-16
FR2421179A1 (fr) 1979-10-26
ZA791061B (en) 1980-03-26
CH640868A5 (de) 1984-01-31
JPS5822120B2 (ja) 1983-05-06
NO790994L (no) 1979-10-02
JPS54130551A (en) 1979-10-09
SE7902866L (sv) 1979-10-16
ES487982A0 (es) 1981-01-16
SE434269B (sv) 1984-07-16
GB2020290B (en) 1982-10-27
DE2911353C2 (da) 1987-10-29
BE875106A (fr) 1979-09-26
DK126679A (da) 1979-10-01

Similar Documents

Publication Publication Date Title
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK164545C (da) Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK156434C (da) Analogifremgangsmaade til fremstilling af sulfonylurinstoffer eller deres fysiologisk acceptable salte
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK149269C (da) Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf
DK150196C (da) Analogifremgangsmaade til fremstilling af 0-(3-amino-2-hydroxypropyl)-amidoximderivater eller farmaceutisk acceptable salte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK162102C (da) Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf
DK149611C (da) Analogifremgangsmaade til fremstilling af trh-analoge tripeptidamider eller terapeutisk acceptable komplexer eller salte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed